Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Financings

DRI Healthcare closes $250M (U.S.) offering of notes

By The Northwire Desk — AI Analysis Mar 25, 2026 · 18:47 DHT · 17.10 DRI Healthcare Trust
DHT · Price

Executive Summary

  • DRI Healthcare Trust’s subsidiary, DRI Healthcare LP, has closed a previously announced private placement of senior secured notes totaling US$250 million.
  • The offering consists of two tranches: US$106 million due in 2031 and US$144 million due in 2033.
  • Net proceeds are designated for debt repayment, fee/expense coverage, and general corporate purposes.

Key Details

  • Total Gross Proceeds: US$250 million.
  • Tranche 1: US$106 million aggregate principal amount of 5.35% senior secured notes due March 24, 2031.
  • Tranche 2: US$144 million aggregate principal amount of 5.65% senior secured notes due March 24, 2033.
  • Interest Payments: Payable semi-annually.
  • Security/Capitalization: Notes rank pari passu with the issuer's existing amended and restated credit agreement and are secured by substantially all assets of DRI Healthcare and its subsidiaries.
  • Use of Proceeds: Repayment of outstanding debt, payment of related fees and expenses, and general corporate purposes.

Notable Quotes

  • None provided in the text.
Read the original news release →

More from DRI Healthcare Trust

Jun 29, 2026 · 07:00

FDA approval on schedule validates $300M Viridian thesis; milestone payment is expected cash outflow for long-dated royalty stream.

M&A / Property May 14, 2026 · 17:00

Record royalty income fails to lift DRI Healthcare shares as investors gauge KalVista buyout impact

Earnings Apr 29, 2026 · 16:05

DRI Healthcare Trust Comments on Proposed Acquisition of KalVista Therapeutics, Inc.

M&A / Property Mar 25, 2026 · 13:37

DRI Healthcare Closes $250M Debt Roll as Leverage Climbs and EBITDA Guidance Slips

Financings Mar 20, 2026 · 17:53

DRI Healthcare Trust closes $108.72M debenture offering

Financings Mar 03, 2026 · 19:07

DRI Healthcare Reports Fourth Quarter and Annual 2025 Results

Earnings